Ticker Details
ProPhase Labs, Inc. ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is also engaged in the research and development of potential over-the-counter drug, natural health products, supplements, personal care & cosmeceutical products.
IPO Date:	May 1, 1994
Sector:	Healthcare
Industry:	Pharma
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 4.16%
Avg Daily Range (30 D):	$0.01 | 12.02%
Avg Daily Range (90 D):	$0.01 | 13.08%

Institutional Daily Volume
Avg Daily Volume:	.04M
Avg Daily Volume (30 D):	.08M
Avg Daily Volume (90 D):	.13M

Trade Size
Avg Trade Size (Sh.):	85
Avg Trade Size (Sh.) (30 D):	3,449
Avg Trade Size (Sh.) (90 D):	3,431

Institutional Trades
Total Institutional Trades:	10
Avg Institutional Trade:	$1.27M
Avg Institutional Trade (30 D):	$4.5M
Avg Institutional Trade (90 D):	$4.5M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.36M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	12.71K

News

Jan 5, 2026 @ 10:00 AM ProPhase Labs Provides Update on Convertible Debt ... Source: Prophase Labs, Inc.

Aug 13, 2025 @ 1:19 PM ProPhase Labs Posts Narrower Q2 Loss Source: Jesterai

Jun 6, 2025 @ 11:00 AM ProPhase Labs Announces Formation of Clinical Scie... Source: N/A

Nov 8, 2024 @ 4:37 AM ProPhase Labs Announces Pricing of Public Offering... Source: N/A

Aug 7, 2024 @ 1:01 PM Antibody Production Market to Surpass USD 36.49 Bi... Source: Sns Insider

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.3	$-1.55	$-1.74
Diluted EPS	$-3.3	$-1.55	$-1.74
Revenue	$3.39M	$.78M	$4.35M
Gross Profit	$1.03M	$.25M	$1.38M
Net Income / Loss	$-24.06M	$-7.4M	$-14.74M
Operating Income / Loss	$-16.99M	$-5.73M	$-18.05M
Cost of Revenue	$2.37M	$.54M	$2.96M
Net Cash Flow	$1.31M	$-.32M	$-.59M
PE Ratio

Splits
Dec 22, 2025	1:10